The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

 
Web www.patentalert.com

< Barley for production of flavor-stable beverage

> Peptide mediated synthesis of metallic and magnetic materials

~ 00482